Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study
PaperCitations, authors & open-access status
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 754 citations, 2016 year and hybrid oa status.
754
Citations
2016
Year
hybrid
OA Status